Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Familial factors affect hair loss types in Koreans, with M type in men, L type in women, and paternal factors influencing male hair loss more.

Animal models are crucial for learning about hair loss and finding treatments.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Hormones and genes affect hair growth and male baldness.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.

AGA linked to inflammation, stress, fibrosis, and disturbed hair follicle stem cells.

Activin A is important for creating new hair follicles.

The document concludes that understanding hair loss and considering medical treatments like minoxidil and finasteride before surgery is important, especially for young patients with rapid hair loss, and that hairline design varies among different ethnicities.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

The document concludes that more research is needed to understand hair loss in men and to find new treatments.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Aminoguanidine increases a specific growth signal in stored hair grafts, which may help them survive better after being transplanted.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

Aminoguanidine increases VEGF in stored hair micrografts, potentially improving their viability after transplant.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Plum-blossom needle therapy shows promise for treating hair loss but needs more research.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

A new nanoemulsion increases oxygen for hair cells, leading to better hair growth.

Sunflower oil was found to promote hair growth in mice with hormone-induced hair loss.

Low-dose oral minoxidil is safe and effective for treating hair loss, with most side effects being mild and reversible.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

Follicular unit grafting is a procedure used to treat hair loss, where small hair grafts are placed into the scalp, with future treatments likely to involve smaller incisions and cell-based therapies.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.